Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310281 · ClinicalTrials.gov registry record · NA
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A NA study, sponsored by Akili Interactive Labs.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03310281 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 84 participants.
The verdict
NCT03310281, a NA study, has completed, sponsored by Akili Interactive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of videogame-like digital therapies as adjunct therapy to antidepressant medications on cognitive deficits associated with major depressive disorder.
Interventions
- DEVICE HOLD: Videogame
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2018-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03310281
The ClinicalTrials.gov registry entry for NCT03310281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HOLD: Videogame is the first listed.
NCT03310281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03310281 about?
NCT03310281 is a clinical study titled "Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)". The purpose of this study is to evaluate the effects of videogame-like digital therapies as adjunct therapy to antidepressant medications on cognitive deficits associated with major depressive disorder.
What is the current status of trial NCT03310281?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2017-12-04. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03310281?
The interventions under investigation include: HOLD: Videogame (DEVICE).
Who is sponsoring clinical trial NCT03310281?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.